Abstract
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant tumor syndrome that may be caused by mutations in the MEN1 gene on 11q13. Loss of function of the tumor suppressor gene MEN1 leads to synchronous or metachronous appearance of neuroendocrine tumors arising from neuroendocrine cells of the parathyroid and pituitary glands, the duodenum and pancreatic islets, and other endocrine organs such as the adrenal cortex. We here present a patient with MEN1 who developed hyperparathyroidism, multiple well differentiated functionally inactive neuroendocrine tumors of the pancreas and an adrenal carcinoma. We describe a new mutation at codon 443 in the coding region of exon 9 in the MEN1 gene, where a cytosine residue was exchanged for adenosine (TCC > TAC) and, consequently, serine for tyrosine (p.Ser443Tyr; c.1327C > A). Also, we provide clinical data that may add to the genotype–phenotype discussion. We conclude that the novel mutation in the MEN1 gene described herein was clinically relevant.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
S.C. Chandrasekharappa, S.C. Guru, P. Manickam, S.E. Olufemi, F.S. Collins, M.R. Emmert-Buck, L.V. Debelenko, Z. Zhuang, I.A. Lubensky, L.A. Liotta, J.S. Crabtree, Y. Wang, B.A. Roe, J. Weisemann, M.S. Boguski, S.K. Agarwal, M.B. Kester, Y.S. Kim, C. Heppner, Q. Dong, A.M. Spiegel, A.L. Burns, S.J. Marx, Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276, 404–407 (1997)
T. Tsukada, Y. Nagamura, N. Ohkura, MEN1 gene and its mutations: basic and clinical implications. Cancer Sci 100, 209–215 (2009)
S.K. Agarwal, C.M. Mateo, S.J. Marx, Rare germline mutations in cyclin-dependent kinase inhibitor genes in MEN1 and related states. J. Clin. Endocrinol. Metab. 94, 1826–1834 (2009)
J.R. Burgess, R.A. Harle, P. Tucker, V. Parameswaran, P. Davies, T.M. Greenaway, J.J. Shepherd, Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch. Surg. 131, 699–702 (1996)
P. Langer, K. Cupisti, D.K. Bartsch, C. Nies, P.E. Goretzki, M. Rothmund, H.D. Röher, Adrenal involvement in multiple endocrine neoplasia type 1. World J. Surg. 26, 891–896 (2002)
J. Waldmann, D.K. Bartsch, P.H. Kann, V. Fendrich, M. Rothmund, P. Langer, Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening. Langenbecks Arch Surg 392, 437–443 (2007)
C. Heppner, M. Reincke, S.K. Agarwal, P. Mora, B. Allolio, A.L. Burns, A.M. Spiegel, S.J. Marx, MEN1 gene analysis in sporadic adrenocortical neoplasms. J. Clin. Endocrinol. Metab. 84, 216–219 (1999)
M. Kjellman, L. Roshani, B.T. Teh, O.P. Kallioniemi, A. Höög, S. Gray, L.O. Farnebo, M. Holst, M. Bäckdahl, C. Larsson, Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16. J. Clin. Endocrinol. Metab. 84, 730–735 (1999)
K.M. Schulte, M. Heinze, M. Mengel, D. Simon, S. Scheuring, K. Köhrer, H.D. Röher, MEN I gene mutations in sporadic adrenal adenomas. Hum. Genet. 105, 603–610 (1999)
B. Görtz, J. Roth, E.J. Speel, A. Krähenmann, R.R. De Krijger, X. Matias-Guiu, S. Muletta-Feurer, K. Rütmann, P. Saremaslani, P.U. Heitz, P. Komminoth, MEN1 gene mutation analysis of sporadic adrenocortical lesions. Int. J. Cancer 80, 373–379 (1999)
O. Zwermann, F. Beuschlein, P. Mora, G. Weber, B. Allolio, M. Reincke, Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors. Eur. J. Endocrinol. 142, 689–695 (2000)
M.M. Bhuiyan, M. Sato, K. Murao, H. Imachi, H. Namihira, T. Ishida, J. Takahara, A. Miyauchi, Differential expression of menin in various adrenal tumors. The role of menin in adrenal tumors. Cancer 92, 1393–1401 (2001)
B. Skogseid, C. Larsson, P.G. Lindgren, E. Kvanta, J. Rastad, E. Theodorsson, L. Wide, E. Wilander, K. Oberg, Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab. 75, 76–81 (1992)
B. Skogseid, J. Rastad, A. Gobl, C. Larsson, K. Backlin, C. Juhlin, G. Akerstrom, K. Oberg, Adrenal lesion in multiple endocrine neoplasia type 1. Surgery 118, 1077–1082 (1995)
C.A. Stratakis, S.J. Marx, Multiple endocrine neoplasias in the era of translational medicine. Horm. Metab. Res. 37, 343–346 (2005)
Y. Yang, X. Hua, In search of tumor suppressing functions of menin. Mol. Cell. Endocrinol. 265–266, 34–41 (2007)
P. Stålberg, M. Santesson, S. Ekeblad, M.H. Lejonklou, B. Skogseid, Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays. Surgery 140, 921–931 (2006)
G.A.J. Chen, M. Wang, S. Farley, L.Y. Lee, L.C. Lee, M.P. Sawicki, Menin promotes the Wnt signaling pathway in pancreatic endocrine cells. Mol. Cancer. Res. 6, 1894–1907 (2008)
J. Bertherat, L. Groussin, X. Bertagna, Mechanisms of disease: adrenocortical tumors–molecular advances and clinical perspectives. Nat. Clin. Pract. Endocrinol. Metab. 2, 632–641 (2006)
S. Schinner, H.S. Willenberg, M. Schott, W.A. Scherbaum, Pathophysiological aspects of Wnt-signalling in endocrine disease. Eur. J. Endocrinol. 160, 731–737 (2009)
Acknowledgments
We would like to acknowledge the contributions by Peter E. Goretzki and Ingo Theuerkauf from the Lukas Hospital Neuss and by Stathis Philippou from the Augusta Teaching Hospital Bochum, Germany.
Disclosure
The authors have nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s12020-011-9463-4
Rights and permissions
About this article
Cite this article
Haase, M., Anlauf, M., Schott, M. et al. A new mutation in the menin gene causes the multiple endocrine neoplasia type 1 syndrome with adrenocortical carcinoma. Endocr 39, 153–159 (2011). https://doi.org/10.1007/s12020-010-9424-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-010-9424-3